TransMedics (TMDX) Depreciation & Amortization (CF) (2018 - 2026)
TransMedics (TMDX) posted quarterly Depreciation & Amortization (CF) of $11.9 million for Q1 2026, up 93.32% year-over-year from $6.1 million in Q1 2025, and up 58.86% quarter-over-quarter from $7.5 million in Q4 2025.
TransMedics (TMDX) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
TransMedics' Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $11.9 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 93.32% year-over-year to $11.9 million; the TTM figure through Mar 2026 stood at $32.8 million (up 53.3% YoY), while the FY2025 annual figure was $27.2 million, up 37.59% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $11.9 million, up from $7.5 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $11.9 million in Q1 2026, with the low at $507000.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $4.3 million (2024), against an average of $4.1 million.
- The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) rose 13.93% in 2022, then jumped 234.27% in 2024.
- TransMedics' Depreciation & Amortization (CF) stood at $1.3 million in 2022, then soared by 180.54% to $3.6 million in 2023, then surged by 57.56% to $5.7 million in 2024, then surged by 31.48% to $7.5 million in 2025, then jumped by 58.86% to $11.9 million in 2026.
- Business Quant data shows TMDX's Depreciation & Amortization (CF) at $11.9 million in Q1 2026, $7.5 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 123.80 Mn |
| 10 | TransMedics | 3.18 Bn | 2.71 Bn | 113.20 Mn | 10.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.30 Mn |
| Jun 30, 2026 | 10.30 Mn |
| Mar 31, 2026 | 11.86 Mn |
| Mar 31, 2026 | 11.86 Mn |
| Dec 31, 2025 | 7.47 Mn |
| Dec 31, 2025 | 7.47 Mn |
| Sep 30, 2025 | 6.80 Mn |
| Sep 30, 2025 | 6.80 Mn |
| Jun 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 6.70 Mn |
| Mar 31, 2025 | 6.14 Mn |
| Mar 31, 2025 | 6.14 Mn |
| Dec 31, 2024 | 5.68 Mn |
| Dec 31, 2024 | 5.68 Mn |
| Sep 30, 2024 | 5.10 Mn |
| Sep 30, 2024 | 5.10 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Mar 31, 2024 | 4.30 Mn |
| Mar 31, 2024 | 4.30 Mn |